The Enterprise Value as of September 2024 (TTM) for IN8bio, Inc. (INAB) is 9.90M

According to IN8bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.90M. This represents a change of -70.23% compared to the average of 33.27M of the last 4 quarters.

IN8bio, Inc. (INAB) Historical Enterprise Value (quarterly & annually)

How has INAB Enterprise Value performed in the past?

The mean historical Enterprise Value of IN8bio, Inc. over the last ten years is 89.03M. The current 9.90M Enterprise Value has changed 1.01% with respect to the historical average. Over the past ten years (40 quarters), INAB's Enterprise Value was at its highest in in the June 2021 quarter at 177.50M. The Enterprise Value was at its lowest in in the March 2018 quarter at 0.

IN8bio, Inc. (INAB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IN8bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IN8bio, Inc. (INAB) Average Enterprise Value

How has INAB Enterprise Value performed in the past?

The current Enterprise Value of IN8bio, Inc. (INAB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

IN8bio, Inc. (INAB) Enterprise Value vs. Peers

How is INAB’s Enterprise Value compared to its peers?

IN8bio, Inc.’s Enterprise Value is less than Reviva Pharmaceuticals Holdings, Inc. (39.93M), less than Cue Biopharma, Inc. (9.93M), less than Lantern Pharma Inc. (24.06M), less than Gracell Biotechnologies Inc. (5.45B), less than Anixa Biosciences, Inc. (101.75M), less than INmune Bio, Inc. (90.68M), less than PolyPid Ltd. (31.20M), less than Zura Bio Limited (42.42M), less than Annexon, Inc. (480.41M), less than Icosavax, Inc. (713.87M), less than Wave Life Sciences Ltd. (514.82M), less than Gain Therapeutics, Inc. (10.68M), greater than TFF Pharmaceuticals, Inc. (1.89M), less than aTyr Pharma, Inc. (138.44M), greater than Palisade Bio, Inc. (-6597681.00), greater than ContraFect Corporation (-1135867.00), greater than Allarity Therapeutics, Inc. (-10898430.00), greater than CNS Pharmaceuticals, Inc. (3.24M), greater than Windtree Therapeutics, Inc. (3.72M),

Build a custom stock screener for IN8bio, Inc. (INAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IN8bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IN8bio, Inc. (INAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IN8bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.